Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Profit After Tax rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 707.61%. This contributed to the annual value of -$39.3 million for FY2024, which is 632.44% up from last year.
  • Per Jaguar Health's latest filing, its Profit After Tax stood at -$9.6 million for Q3 2025, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Jaguar Health's Profit After Tax's 5-year high stood at -$7.9 million during Q3 2023, with a 5-year trough of -$18.2 million in Q1 2022.
  • Moreover, its 5-year median value for Profit After Tax was -$10.6 million (2025), whereas its average is -$11.2 million.
  • As far as peak fluctuations go, Jaguar Health's Profit After Tax crashed by 6327.97% in 2021, and later surged by 4250.59% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Profit After Tax stood at -$14.3 million in 2021, then surged by 42.51% to -$8.2 million in 2022, then decreased by 13.08% to -$9.3 million in 2023, then dropped by 9.94% to -$10.2 million in 2024, then rose by 5.73% to -$9.6 million in 2025.
  • Its Profit After Tax stands at -$9.6 million for Q3 2025, versus -$10.6 million for Q2 2025 and -$10.6 million for Q1 2025.